AU2018298862A1 - Propionic acid and/or butyric acid for use in the prophylactic and/or supporting therapeutic treatment of parkinson's disease - Google Patents

Propionic acid and/or butyric acid for use in the prophylactic and/or supporting therapeutic treatment of parkinson's disease Download PDF

Info

Publication number
AU2018298862A1
AU2018298862A1 AU2018298862A AU2018298862A AU2018298862A1 AU 2018298862 A1 AU2018298862 A1 AU 2018298862A1 AU 2018298862 A AU2018298862 A AU 2018298862A AU 2018298862 A AU2018298862 A AU 2018298862A AU 2018298862 A1 AU2018298862 A1 AU 2018298862A1
Authority
AU
Australia
Prior art keywords
salts
butyric acid
esters
agent
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018298862A
Other languages
English (en)
Inventor
Aiden Haghikia
Horst Przuntek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2018298862A1 publication Critical patent/AU2018298862A1/en
Priority to AU2021273627A priority Critical patent/AU2021273627B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/05—Propionic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2018298862A 2017-07-13 2018-07-13 Propionic acid and/or butyric acid for use in the prophylactic and/or supporting therapeutic treatment of parkinson's disease Abandoned AU2018298862A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2021273627A AU2021273627B2 (en) 2017-07-13 2021-11-26 Agent for the prophylactic and/or supportive therapeutic treatment of Parkinson's disease

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102017115819.7 2017-07-13
DE102017115819.7A DE102017115819A1 (de) 2017-07-13 2017-07-13 Mittel zur prophylaktischen und/oder unterstützenden therapeutischen Behandlung von Morbus Parkinson
PCT/EP2018/069089 WO2019012108A1 (de) 2017-07-13 2018-07-13 Propion- und/oder buttersäure zur verwendung zur prophylaktischen und/oder unterstützenden therapeutischen behandlung von morbus parkinson

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2021273627A Division AU2021273627B2 (en) 2017-07-13 2021-11-26 Agent for the prophylactic and/or supportive therapeutic treatment of Parkinson's disease

Publications (1)

Publication Number Publication Date
AU2018298862A1 true AU2018298862A1 (en) 2020-01-23

Family

ID=63108510

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2018298862A Abandoned AU2018298862A1 (en) 2017-07-13 2018-07-13 Propionic acid and/or butyric acid for use in the prophylactic and/or supporting therapeutic treatment of parkinson's disease
AU2021273627A Active AU2021273627B2 (en) 2017-07-13 2021-11-26 Agent for the prophylactic and/or supportive therapeutic treatment of Parkinson's disease

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2021273627A Active AU2021273627B2 (en) 2017-07-13 2021-11-26 Agent for the prophylactic and/or supportive therapeutic treatment of Parkinson's disease

Country Status (10)

Country Link
US (2) US20200163914A1 (enExample)
EP (1) EP3651754B1 (enExample)
JP (1) JP7206223B2 (enExample)
KR (1) KR20200027976A (enExample)
CN (1) CN110996933A (enExample)
AU (2) AU2018298862A1 (enExample)
BR (1) BR112020000570A2 (enExample)
CA (1) CA3067728A1 (enExample)
DE (1) DE102017115819A1 (enExample)
WO (1) WO2019012108A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021048440A1 (en) 2019-09-13 2021-03-18 Basf Se Composition for the treatment of neurodegenerative diseases
CN111450238A (zh) * 2020-03-31 2020-07-28 上海交通大学医学院附属瑞金医院 骨钙素或丙酸在制备抗帕金森病药物中的应用
CN113332266A (zh) * 2021-06-10 2021-09-03 徐州医科大学 含丁酸的治疗与预防神经退行性疾病的药物及丁酸的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19503598A1 (de) * 1995-02-03 1996-08-08 Zuzana Dr Cully Verfahren zur fermentativen Herstellung von Propionsäure oder Buttersäure bzw. deren Salze
NL1009990C2 (nl) * 1998-09-02 2000-03-15 Sibeco Chemicals Voedingssupplement en werkwijze voor het vervaardigen van zulk voedingssupplement.
US20060105962A1 (en) * 2004-11-14 2006-05-18 Robinson Robert O A Tonic to maintain intestinal flora
WO2012095461A1 (de) * 2011-01-12 2012-07-19 Albert Daxer Getränk
EP3019181A4 (en) * 2013-07-09 2016-09-21 Puretech Ventures Llc COMPOSITIONS WITH COMBINATIONS OF BIOACTIVE MOLECULARS DERIVED FROM MICROBOTS FOR TREATING DISEASES
CN105055457A (zh) * 2015-08-06 2015-11-18 温州医科大学附属第二医院 一种防治阿尔茨海默病的药物及其制备方法和应用
DE102016103242A1 (de) * 2016-02-24 2017-08-24 Flexopharm Brain Gmbh & Co. Kg Mittel zur unterstützenden Immunmodulation
WO2017091072A1 (en) * 2015-11-27 2017-06-01 Birrbeheer B.V. Butyrate salts for use in inflammatory diseases
US11065217B2 (en) * 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Also Published As

Publication number Publication date
US20200163914A1 (en) 2020-05-28
EP3651754A1 (de) 2020-05-20
DE102017115819A1 (de) 2019-01-17
KR20200027976A (ko) 2020-03-13
AU2021273627A1 (en) 2021-12-16
CA3067728A1 (en) 2019-01-17
BR112020000570A2 (pt) 2020-07-14
JP2020526485A (ja) 2020-08-31
CN110996933A (zh) 2020-04-10
WO2019012108A1 (de) 2019-01-17
US20220313634A1 (en) 2022-10-06
EP3651754C0 (de) 2025-04-30
AU2021273627B2 (en) 2024-01-25
EP3651754B1 (de) 2025-04-30
JP7206223B2 (ja) 2023-01-17

Similar Documents

Publication Publication Date Title
AU2021273627B2 (en) Agent for the prophylactic and/or supportive therapeutic treatment of Parkinson's disease
US11471432B2 (en) Supporting immunomodulatory agent
JP2024096784A (ja) 老化防止剤及び老化防止方法
US11865091B2 (en) Supporting immunomodulatory agent
JPH07507569A (ja) ヒトの窒素保持の促進方法
JP5498521B2 (ja) 放射線障害軽減剤
WO2012123491A1 (en) Use of type a2 proanthocyanidins in gastroprotected form for the treatment of acute cystitis induced by fimbriated bacterial forms e
US20130022673A1 (en) Enhancement of magnesium uptake in mammals
EP0704211B1 (en) Preventive or alleviating agent for medical symptoms caused by delayed allergy reactions
US11596166B2 (en) Compositions and methods for treating aging and/or improving human health
JP2006342148A (ja) 寝つきまたは寝起き改善用経口剤
US11458150B2 (en) Methylphosphinic acid compositions and methods for reducing aging
JP5410152B2 (ja) 貧血予防用組成物
JP5196708B2 (ja) アスタキサンチン及び／又はそのエステルを有効成分とする筋萎縮改善剤及び飲食物
CA2166427A1 (en) Use of bile acids for preparing medicaments for the treatment of skin diseases
JPWO2009054360A1 (ja) 内臓脂肪特異的低減剤
JPH02142732A (ja) 肥満並びに肥満に関連する各種疾患の治療剤
US20180193312A1 (en) Nutraceutical composition and dosing regimen
CN121102248A (zh) 一种组合物及其制备方法和在保护大脑健康中的应用
JP6434312B2 (ja) 組成物、飲食品、内臓脂肪低減剤、血糖値低減剤、内臓脂肪低減用の飲食品、及び血糖値低減用の飲食品
CN102526088A (zh) 维生素b12口服制剂的改进配方及用途
HK1092057A1 (en) HUMAN β-DEFENSIN SECRETION PROMOTER
HK1092057B (en) HUMAN β-DEFENSIN SECRETION PROMOTER

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted